Cargando…
Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias – assessment of clinical outcome, post induction, end of treatment and minimal residual disease
INTRODUCTION: The extracellular matrix protein hyaluronan acid plays an active in role in tumor cell proliferation and invasion. Hyaluronan acid receptors, namely CD168 or the receptor for hyaluronan acid-mediated motility (RHAMM) and CD44 have been implicated in promoting malignancy. There is a lac...
Autores principales: | Shalini, Chinnathambi Narayanan Sai, Suman, Febe Renjitha, Jacob, Jerusha Samuela, Rajendran, Rithika, Scott, Julius Xavier, Latha, Magadha Sneha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200675/ https://www.ncbi.nlm.nih.gov/pubmed/30370408 http://dx.doi.org/10.1016/j.htct.2018.01.008 |
Ejemplares similares
-
The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury
por: Cui, Zheng, et al.
Publicado: (2018) -
Pancytopenia – (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia
por: Raja, Shruti, et al.
Publicado: (2015) -
Secondary acute myeloid leukemia in a child treated for retinoblastoma: A case report with review of literature
por: Sneha, Latha M., et al.
Publicado: (2020) -
Is it essential to inform the positive donor? A 2-year study in a tertiary care hospital
por: Suman, Febe Renjitha, et al.
Publicado: (2011) -
Hyaluronan stimulates pancreatic cancer cell motility
por: Cheng, Xiao-Bo, et al.
Publicado: (2015)